Follow
Lisette Pregelj
Title
Cited by
Cited by
Year
Pongamia pinnata: An Untapped Resource for the Biofuels Industry of the Future
PT Scott, L Pregelj, N Chen, JS Hadler, MA Djordjevic, PM Gresshoff
Bioenergy Research 1, 2-11, 2008
3532008
Deconstructing and reconstructing the capability hierarchy
D Hine, R Parker, L Pregelj, ML Verreynne
Industrial and Corporate Change 23 (5), 1299-1325, 2014
1002014
Precision medicines have faster approvals based on fewer and smaller trials than other medicines
L Pregelj, TJ Hwang, DC Hine, EB Siegel, RT Barnard, JJ Darrow, ...
Health Affairs 37 (5), 724-731, 2018
372018
Transcription profiling of the isoflavone phenylpropanoid pathway in soybean in response to Bradyrhizobium japonicum inoculation
L Pregelj, JR McLanders, PM Gresshoff, PM Schenk
Functional Plant Biology 38 (1), 13-24, 2010
172010
Changes in clinical trial length
L Pregelj, ML Verreynne, D Hine
Nature Reviews. Drug Discovery 14 (5), 307, 2015
152015
Assessing the impact of US Food and Drug Administration breakthrough therapy designation timing on trial characteristics and development speed
L Pregelj, DC Hine, AS Kesselheim, JJ Darrow
Clinical Pharmacology & Therapeutics 110 (4), 1018-1024, 2021
132021
Working hard or hardly working? Regulatory bottlenecks in developing a COVID-19 vaccine
L Pregelj, DC Hine, MG Oyola-Lozada, TP Munro
Trends in Biotechnology 38 (9), 943-947, 2020
132020
Commercializing university research to mitigate simultaneous change stimuli: An exemplar case from the Australian higher education sector
D Hine, L Pregelj, M McManus
World Scientific Reference on Innovation: Volume 1: University Technology …, 2018
42018
Capability development along the capability lifecycle: Evidence from the pharmaceutical industry
L Pregelj
42013
Functional genomics of the regulation of nodule number in legumes
PM Gresshoff, G Gualtieri, T Laniya, A Indrasumunar, A Miyahara, ...
Biological nitrogen fixation, sustainable agriculture and the environment …, 2005
42005
Delivering impactful solutions for the bioeconomy
B Hankamer, L Pregelj, S O’Kane, K Hussey, D Hine
Trends in Plant Science, 2023
22023
Speeding up drug development: Productivity and innovation speed in the biosciences
L Pregelj, ML Verreynne, D Hine
The Australian Graduate School of Entrepreneurship, Swinburne University of …, 2010
22010
Small Pharmaceutical Firms Building Capabilities to Compete Along the Global Research and Development Pipeline
L Pregelj, ML Verreynne, D Hine
International Entrepreneurship in the Life Sciences, 2011
12011
Are manufacturing patents to blame for biosimilar market launch delays?
R Williamson, T Munro, D Ascher, A Robertson, L Pregelj
Value in Health 27 (3), 287-293, 2024
2024
Restoring Australia’s long-term innovation requires investment in basic research
RS Harrison, RT Barnard, L Pregelj
Microbiology Australia 44 (1), 57-61, 2023
2023
Progress of precision medicines onto the Australian market
L Pregelj, D Hine, K Hussey
Australasian Biotechnology 28 (3), 38-40, 2018
2018
Trading-Off Innovation Speed for Knowledge During Drug Development
L Pregelj, DC Hine, M Becerra, ML Verreynne
Academy of Management Proceedings 2018 (1), 15704, 2018
2018
Submission: Commonwealth Department of Health, re Consultation on the Draft Implementation Plan-National Health Genomics Policy Framework
M Mangelsdorf, A Crowden, J Lamont, D Hine, D Morrison, K Hussey, ...
The University of Queensland, 2018
2018
Brisbane Innovation Scorecard 2012. Brisbane City Council and Brisbane Marketing Economic Development Board
J Steen, ML Verreynne, L Pregelj, M Foster, J Cretchley
2012
Capability development in the pharmaceutical commercialisation process
L Pregelj, ML Verreynne, D Hine
Auckland University of Technology, 2011
2011
The system can't perform the operation now. Try again later.
Articles 1–20